Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Andress, Dennis L.
70  Ergebnisse:
Personensuche X
?
1

Atrasentan and renal events in patients with type 2 diabete..:

Heerspink, Hiddo J L ; Parving, Hans-Henrik ; Andress, Dennis L...
The Lancet.  393 (2019)  10184 - p. 1937-1947 , 2019
Link: https://doi.org/10.1016/..
 
?
2

Relationship Between Atrasentan Concentrations and Urinary ..:

Lin, Chih-Wei ; Mostafa, Nael M. ; L. Andress, Dennis...
Clinical Therapeutics.  40 (2018)  2 - p. 242-251 , 2018
Link: https://doi.org/10.1016/..
 
?
3

Baseline characteristics and enrichment results from the SO..:

Heerspink, Hiddo J.L. ; Andress, Dennis L. ; Bakris, George...
Diabetes, Obesity and Metabolism.  20 (2018)  8 - p. 1829-1835 , 2018
Link: https://doi.org/10.1111/..
 
?
4

Rationale and protocol of the Study Of diabetic Nephropathy..:

Heerspink, Hiddo J. L. ; Andress, Dennis L. ; Bakris, George...
Diabetes, Obesity and Metabolism.  20 (2018)  6 - p. 1369-1376 , 2018
Link: https://doi.org/10.1111/..
 
?
5

Longitudinal Assessment of the Effect of Atrasentan on Thor..:

Webb, David J. ; Coll, Blai ; Heerspink, Hiddo J. L....
Drugs in R&D.  17 (2017)  3 - p. 441-448 , 2017
Link: https://doi.org/10.1007/..
 
?
6

Comparison of exposure response relationship of atrasentan ..:

Heerspink, Hiddo J. L. ; Makino, Hirofumi ; Andress, Dennis...
Diabetes, Obesity and Metabolism.  19 (2017)  4 - p. 545-552 , 2017
Link: https://doi.org/10.1111/..
 
?
7

The effects of atrasentan on urinary metabolites in patient..:

Pena, Michelle J. ; de Zeeuw, Dick ; Andress, Dennis...
Diabetes, Obesity and Metabolism.  19 (2017)  5 - p. 749-753 , 2017
Link: https://doi.org/10.1111/..
 
?
8

Prediction of the effect of atrasentan on renal and heart f..:

Schievink, Bauke ; de Zeeuw, Dick ; Smink, Paul A...
European Journal of Preventive Cardiology.  23 (2015)  7 - p. 758-768 , 2015
Link: https://doi.org/10.1177/..
 
?
9

Reply to "The role of fibroblast growth factor-23 in left a..:

Tamez, Hector ; Andress, Dennis ; Solomon, Scott D..
American Heart Journal.  165 (2013)  5 - p. e23 , 2013
Link: https://doi.org/10.1016/..
 
?
10

The selective type A endothelin antagonist atrasentan reduc..:

Andress, Dennis L. ; de Zeeuw, Dick ; Parving, Hans-Henrik
Life Sciences.  93 (2013)  25-26 - p. e58-e59 , 2013
Link: https://doi.org/10.1016/..
 
?
11

Paricalcitol Versus Ergocalciferol for Secondary Hyperparat..:

Kovesdy, Csaba P. ; Lu, Jun L. ; Malakauskas, Sandra M....
American Journal of Kidney Diseases.  59 (2012)  1 - p. 58-66 , 2012
Link: https://doi.org/10.1053/..
 
?
12

Clinical efficacy of the selective endothelin A receptor an..:

Andress, Dennis L. ; Coll, Blai ; Pritchett, Yili...
Life Sciences.  91 (2012)  13-14 - p. 739-742 , 2012
Link: https://doi.org/10.1016/..
 
?
13

Vitamin D reduces left atrial volume in patients with left ..:

Tamez, Hector ; Zoccali, Carmine ; Packham, David...
American Heart Journal.  164 (2012)  6 - p. 902-909.e2 , 2012
Link: https://doi.org/10.1016/..
 
?
14

The use of group sequential, information-based sample size ..:

Pritchett, Yili ; Jemiai, Yannis ; Chang, Yuchiao...
Clinical Trials.  8 (2011)  2 - p. 165-174 , 2011
Link: https://doi.org/10.1177/..
 
?
15

Paricalcitol for reduction of albuminuria in diabetes – Aut..:

de Zeeuw, Dick ; Andress, Dennis
The Lancet.  377 (2011)  9766 - p. 636-637 , 2011
Link: https://doi.org/10.1016/..
 
1-15